Neovacs (STU:0LW) Ending Cash Position : €0.23 Mil (As of Jun. 2024)

View and export this data going back to 2013. Start your Free Trial

What is Neovacs Ending Cash Position?

Neovacs's Ending Cash Position for the quarter that ended in Jun. 2024 was €0.23 Mil.

Neovacs's quarterly Ending Cash Position declined from Jun. 2023 (€6.19 Mil) to Dec. 2023 (€0.89 Mil) and declined from Dec. 2023 (€0.89 Mil) to Jun. 2024 (€0.23 Mil).

Neovacs's annual Ending Cash Position declined from Dec. 2021 (€33.10 Mil) to Dec. 2022 (€7.09 Mil) and declined from Dec. 2022 (€7.09 Mil) to Dec. 2023 (€0.89 Mil).

Neovacs Ending Cash Position Historical Data

The historical data trend for Neovacs's Ending Cash Position can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Neovacs Ending Cash Position Chart

Neovacs Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Ending Cash Position

Get a 7-Day Free Trial

1.30

10.07

33.10

7.09

0.89

Neovacs Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Ending Cash Position	Get a 7-Day Free Trial															33.00	7.09	6.19	0.89	0.23

Neovacs Ending Cash Position Calculation

Ending Cash Position is the cash and cash equivalents balance at the end of the accounting period, as indicated on the Cash Flow statement. It is equal to the Beginning Cash Position plus the Net Change in Cash.

Neovacs's Ending Cash Position for the fiscal year that ended in Dec. 2023 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	7.086	+	-6.199
	=	0.89

Neovacs's Ending Cash Position for the quarter that ended in Jun. 2024 is calculated as

Ending Cash Position	=	Beginning Cash Position	+	Net Change in Cash
	=	0.887	+	-0.655
	=	0.23

Neovacs Ending Cash Position Related Terms

Thank you for viewing the detailed overview of Neovacs's Ending Cash Position provided by GuruFocus.com. Please click on the following links to see related term pages.

Neovacs Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Neovacs SA (STU:0LW) » Definitions » Ending Cash Position

Comparable Companies

Traded in Other Exchanges

0W8U:UK ALNEV:France 0LW:Germany

Address

3-5, Impasse Reille, Paris, FRA, 75014

Website

http://www.neovacs.fr

Neovacs SA is a biotechnology company focused on the development of "Kinoids", therapeutic vaccines for the treatment of autoimmune, inflammatory diseases, allergies and cancer.

Neovacs Headlines

No Headlines